SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-067113
Filing Date
2023-06-01
Accepted
2023-06-01 16:50:44
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317417-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2317417-2_3seq1.xml 3 1554
  Complete submission text file 0001104659-23-067113.txt   3121
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 23985399

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)